Bookmark and Share
Scarb1 (geneid:20778) - Gene BioActivity Data
Also known as: AI120173, CD36, Cd36l1, Cla-1, Cla1, D5Ertd460e, Hdlq1, Hlb398, SR-B1, SR-BI, SRBI, Srb1, mSR-BI.
BioActivity Outcomes:
Active(3928)
 
 
Inactive(633959)
 
 
Inconclusive(1163)
 
 
BioAssay Types:
Screening(636830)
 
 
 
 
Confirmatory(2166)
 
 
 
 
BioActivity Types:
AC50(1656)
 
 
 
 
Substance Types:
Chemical(639050)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 32    Data Row: 639050   Total Pages: 31953   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID99351013]
[CID46897918]
AC50_uM 0.000536HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set7 [AID588833, Type: confirmatory] [gi:14389423]
View
2
[SID99351013]
[CID46897918]
AC50_uM 0.000598HDL Inhib: Reversibility Measured in Cell-Based System Using Plate Reader - 2085-15_Inhibitor_Dose_DryPowder_Activity [AID602154, Type: confirmatory] [gi:14389423]
View
3
[SID125299406]
[CID53377409]
AC50_uM 0.000909HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set5 [AID588754, Type: confirmatory] [gi:14389423]
View
4
[SID125299396]
[CID53377428]
AC50_uM 0.000927HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set6 [AID588828, Type: confirmatory] [gi:14389423]
View
5
[SID99351013]
[CID46897918]
AC50_uM 0.000987HDL Inhib: Reversibility Measured in Cell-Based System Using Plate Reader - 2085-14_Inhibitor_Dose_DryPowder_Activity [AID588831, Type: confirmatory] [gi:14389423]
View
6
[SID125333454]
[CID53393835]
AC50_uM 0.00122HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set6 [AID588828, Type: confirmatory] [gi:14389423]
View
7
[SID134356539]
[CID44202943]
AC50_uM 0.00202HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set10 [AID624029, Type: confirmatory] [gi:14389423]
View
8
[SID125299396]
[CID53377428]
AC50_uM 0.00228HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set5 [AID588754, Type: confirmatory] [gi:14389423]
View
9
[SID125299410]
[CID1458944]
AC50_uM 0.00276HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set5 [AID588754, Type: confirmatory] [gi:14389423]
View
10
[SID125299400]
[CID53377439]
AC50_uM 0.00281HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set5 [AID588754, Type: confirmatory] [gi:14389423]
View
11
[SID125081990]
[CID53347989]
AC50_uM 0.00319HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set6 [AID588828, Type: confirmatory] [gi:14389423]
View
12
[SID125299400]
[CID53377439]
AC50_uM 0.00366HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set6 [AID588828, Type: confirmatory] [gi:14389423]
View
13
[SID134959010]
[CID16038218]
AC50_uM 0.00402HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set10 [AID624029, Type: confirmatory] [gi:14389423]
View
14
[SID125082028]
[CID53347941]
AC50_uM 0.00433HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588392, Type: confirmatory] [gi:14389423]
View
15
[SID99351013]
[CID46897918]
AC50_uM 0.005HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set10 [AID624029, Type: confirmatory] [gi:14389423]
View
16
[SID126700837]
[CID53377439]
AC50_uM 0.00538HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set10 [AID624029, Type: confirmatory] [gi:14389423]
View
17
[SID125082000]
[CID44483406]
AC50_uM 0.00598HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set5 [AID588754, Type: confirmatory] [gi:14389423]
View
18
[SID125333448]
[CID53393841]
AbsAC40_uM 0.00607HDL Orthogonal Assay: Alexa 488-HDL Measured in Cell-Based System Using Plate Reader - 2085-03_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588810, Type: confirmatory] [gi:14389423]
View
19
[SID126700837]
[CID53377439]
AC50_uM 0.00618HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set7 [AID588833, Type: confirmatory] [gi:14389423]
View
20
[SID125299402]
[CID53377436]
AC50_uM 0.0063HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_Dose_DryPowder_Activity_Set6 [AID588828, Type: confirmatory] [gi:14389423]
View